tiprankstipranks
PharmaNutra SpA (IT:PHN)
:PHN
Italy Market
Want to see IT:PHN full AI Analyst Report?

PharmaNutra SpA (PHN) Stock Forecast & Price Target

12 Followers
See the Price Targets and Ratings of:

PHN Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
PharmaNutra
SpA
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

PHN Stock 12 Month Forecast

There Are No Analyst Ratings for IT:PHN In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

PHN Financial Forecast

PHN Earnings Forecast

The previous quarter’s earnings for PHN were €0.36.
The previous quarter’s earnings for PHN were €0.36.

PHN Sales Forecast

The previous quarter’s earnings for PHN were €32.71M.
The previous quarter’s earnings for PHN were €32.71M.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Intermonte
€89€98
Buy
19.22%
Upside
Reiterated
05/12/26
Analyst Reiterates Buy on PharmaNutra as Global Momentum Builds and Price Target Rises to €98, Highlighting Upside vs Peers
Berenberg Bank Analyst forecast on IT:PHN
Berenberg Bank
Berenberg Bank
€85€93
Buy
13.14%
Upside
Reiterated
05/12/26
Berenberg Bank Sticks to Their Buy Rating for PharmaNutra SpA (PHN)
TP ICAP MIDCAP Analyst forecast on IT:PHN
TP ICAP MIDCAP
TP ICAP MIDCAP
€74
Buy
-9.98%
Downside
Reiterated
02/02/26
PharmaNutra: Strong US SiderAL Momentum and Discounted Valuation Support Reiterated Buy Rating for 1H 2026
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Intermonte
€89€98
Buy
19.22%
Upside
Reiterated
05/12/26
Analyst Reiterates Buy on PharmaNutra as Global Momentum Builds and Price Target Rises to €98, Highlighting Upside vs Peers
Berenberg Bank Analyst forecast on IT:PHN
Berenberg Bank
Berenberg Bank
€85€93
Buy
13.14%
Upside
Reiterated
05/12/26
Berenberg Bank Sticks to Their Buy Rating for PharmaNutra SpA (PHN)
TP ICAP MIDCAP Analyst forecast on IT:PHN
TP ICAP MIDCAP
TP ICAP MIDCAP
€74
Buy
-9.98%
Downside
Reiterated
02/02/26
PharmaNutra: Strong US SiderAL Momentum and Discounted Valuation Support Reiterated Buy Rating for 1H 2026
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
JBIOJade Biosciences
GHRSGH Research
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering PharmaNutra SpA

3 Months
Success Rate
9/15 ratings generated profit
60%
Average Return
+5.53%
Copying Giorgio Tavolini's trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +5.53% per trade.
1 Year
Corentin MartyTP ICAP MIDCAP
Success Rate
8/10 ratings generated profit
80%
Average Return
+39.06%
Copying Corentin Marty's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +39.06% per trade.
2 Years
Corentin MartyTP ICAP MIDCAP
Success Rate
10/10 ratings generated profit
100%
Average Return
+68.69%
Copying Corentin Marty's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +68.69% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PHN Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
0
0
0
0
0
Buy
3
4
2
2
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
4
2
2
0
In the current month, PHN has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PHN average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

PHN Stock Forecast FAQ

What is IT:PHN’s average 12-month price target, according to analysts?
Currently, no data Available
What is IT:PHN’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IT:PHN, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is PharmaNutra SpA a Buy, Sell or Hold?
      Currently, no data Available
      What is PharmaNutra SpA’s share price target?
      Currently, no data Available
      What do analysts say about PharmaNutra SpA?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of PharmaNutra SpA?
      To buy shares of IT:PHN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.